Drug Combo Ups Ulcer Risk After Cryoablation in Patients With HCC
Patients with hepatocellular carcinoma should be switched from a PD-1, TKI combination to monotherapy after cryoablation. The study was published as a preprint and has not yet been peer reviewed.
First Look
source https://www.medscape.com/viewarticle/969738?src=rss
First Look
source https://www.medscape.com/viewarticle/969738?src=rss
Comments
Post a Comment